Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Japan’s Prescription Drug Market to Near 12 Trillion Yen in FY2030: IQVIA
December 1, 2025
- Japan Dementia Drug Market to Hit 280 Billion Yen by 2040: Fuji Keizai
December 1, 2025
- JFCR, NEC, Taiho Launch AI-Driven R&D for Cancer Vaccines
December 1, 2025
- Eisai Files Subcutaneous Leqembi Autoinjector in Japan
December 1, 2025
- MSD to End Gardasil Sales in Japan as Use Shifts to 9-Valent HPV Shot
December 1, 2025
- Insmed Japan to Double Sales Force with Brensocatib Launch on the Horizon
November 28, 2025
- Chugai’s Market Cap Tops 14 Trillion Yen, Eyes Further Growth through “Co-Creation”: CEO
November 28, 2025
- Teijin to Receive US$5 Million Milestone as Narcolepsy Drug Enters European PI
November 28, 2025
- Izervay, Vorzzz, Dormicum Syrup Now Available in Japan
November 28, 2025
- Meiji Seeks Label Expansion for Laserphyrin in Cervical Intraepithelial Neoplasia
November 28, 2025
- Jardiance Tops 7 Categories in October Promotion Rankings: Intage
November 28, 2025
- Otsuka’s Sibeprenlimab Earns FDA’s Accelerated Nod for IgAN
November 27, 2025
- Japan PIII Trial Begins for Kagoshima University Spinout’s Oncolytic Virus
November 27, 2025
- Mochida, Ayumi Curb Shipments of Humira Biosimilar 40 mg amid Surging Orders
November 27, 2025
- Toray Out-Licenses Peripheral Neuropathy Drug to Sanodyne
November 27, 2025
- Renalys’ IgAN Drug Nets Positive PIII Data, 2026 Japan Filing on Track
November 27, 2025
- Rolling Submission for Leqembi SC Starting Dose Completed in US
November 27, 2025
- Taisho Touts Low Next-Day Carryover for New Insomnia Drug Vorzzz
November 26, 2025
- Alfresa/Mycenax-Led Biosimilar JV to Be Named Alfenax Biologics
November 26, 2025
- Chugai Targets Japan Filing in 2026 for Ranibizumab Eye Implant
November 26, 2025
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…